Annual Total Assets
$11.39 B
+$558.10 M+5.15%
31 December 2023
Summary:
Jazz Pharmaceuticals annual total assets is currently $11.39 billion, with the most recent change of +$558.10 million (+5.15%) on 31 December 2023. During the last 3 years, it has fallen by -$905.28 million (-7.36%). JAZZ annual total assets is now -7.36% below its all-time high of $12.30 billion, reached on 31 December 2021.JAZZ Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$12.26 B
+$893.85 M+7.87%
30 September 2024
Summary:
Jazz Pharmaceuticals quarterly total assets is currently $12.26 billion, with the most recent change of +$893.85 million (+7.87%) on 30 September 2024. Over the past year, it has increased by +$862.36 million (+7.57%). JAZZ quarterly total assets is now -7.24% below its all-time high of $13.21 billion, reached on 30 June 2021.JAZZ Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
JAZZ Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | +7.6% |
| 3 y3 years | -7.4% | -0.3% |
| 5 y5 years | +105.7% | +121.3% |
JAZZ Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -7.4% | +5.2% | -0.3% | +18.0% |
| 5 y | 5 years | -7.4% | +105.7% | -7.2% | +135.0% |
| alltime | all time | -7.4% | >+9999.0% | -7.2% | >+9999.0% |
Jazz Pharmaceuticals Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $12.26 B(+7.9%) |
| June 2024 | - | $11.36 B(+0.3%) |
| Mar 2024 | - | $11.33 B(-0.6%) |
| Dec 2023 | $11.39 B(+5.2%) | $11.39 B(+1.7%) |
| Sept 2023 | - | $11.20 B(-0.5%) |
| June 2023 | - | $11.26 B(+1.9%) |
| Mar 2023 | - | $11.05 B(+2.0%) |
| Dec 2022 | $10.84 B(-11.9%) | $10.84 B(+4.3%) |
| Sept 2022 | - | $10.38 B(-7.3%) |
| June 2022 | - | $11.20 B(-4.8%) |
| Mar 2022 | - | $11.77 B(-4.3%) |
| Dec 2021 | $12.30 B(+88.2%) | $12.30 B(-1.4%) |
| Sept 2021 | - | $12.48 B(-5.6%) |
| June 2021 | - | $13.21 B(+95.6%) |
| Mar 2021 | - | $6.76 B(+3.4%) |
| Dec 2020 | $6.54 B(+18.0%) | $6.54 B(+3.9%) |
| Sept 2020 | - | $6.29 B(+3.7%) |
| June 2020 | - | $6.07 B(+16.3%) |
| Mar 2020 | - | $5.22 B(-5.8%) |
| Dec 2019 | $5.54 B(+6.4%) | $5.54 B(+0.2%) |
| Sept 2019 | - | $5.53 B(+0.7%) |
| June 2019 | - | $5.49 B(+3.9%) |
| Mar 2019 | - | $5.28 B(+1.5%) |
| Dec 2018 | $5.20 B(+1.6%) | $5.20 B(-5.1%) |
| Sept 2018 | - | $5.49 B(+2.6%) |
| June 2018 | - | $5.35 B(+1.2%) |
| Mar 2018 | - | $5.29 B(+3.2%) |
| Dec 2017 | $5.12 B(+6.7%) | $5.12 B(+2.5%) |
| Sept 2017 | - | $5.00 B(+4.1%) |
| June 2017 | - | $4.80 B(-0.2%) |
| Mar 2017 | - | $4.82 B(+0.3%) |
| Dec 2016 | $4.80 B(+44.0%) | $4.80 B(-2.6%) |
| Sept 2016 | - | $4.93 B(+43.0%) |
| June 2016 | - | $3.45 B(-2.5%) |
| Mar 2016 | - | $3.53 B(+6.1%) |
| Dec 2015 | $3.33 B | $3.33 B(-3.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2015 | - | $3.46 B(+2.1%) |
| June 2015 | - | $3.39 B(+4.8%) |
| Mar 2015 | - | $3.24 B(-3.0%) |
| Dec 2014 | $3.34 B(+49.2%) | $3.34 B(-0.3%) |
| Sept 2014 | - | $3.35 B(+6.1%) |
| June 2014 | - | $3.16 B(-1.3%) |
| Mar 2014 | - | $3.20 B(+42.8%) |
| Dec 2013 | $2.24 B(+13.8%) | $2.24 B(+2.4%) |
| Sept 2013 | - | $2.19 B(+4.4%) |
| June 2013 | - | $2.09 B(+4.2%) |
| Mar 2013 | - | $2.01 B(+2.2%) |
| Dec 2012 | $1.97 B(+675.5%) | $1.97 B(+13.9%) |
| Sept 2012 | - | $1.73 B(+1.7%) |
| June 2012 | - | $1.70 B(+89.6%) |
| Mar 2012 | - | $895.36 M(+253.1%) |
| Dec 2011 | $253.57 M(+86.8%) | $253.57 M(+22.0%) |
| Sept 2011 | - | $207.81 M(+7.4%) |
| June 2011 | - | $193.41 M(+25.4%) |
| Mar 2011 | - | $154.18 M(+13.6%) |
| Dec 2010 | $135.73 M(+26.4%) | $135.73 M(+39.5%) |
| June 2010 | - | $97.26 M(-8.8%) |
| Mar 2010 | - | $106.71 M(-0.6%) |
| Dec 2009 | $107.40 M(-8.6%) | $107.40 M(+5.1%) |
| Sept 2009 | - | $102.17 M(-5.9%) |
| June 2009 | - | $108.57 M(-1.2%) |
| Mar 2009 | - | $109.94 M(-6.4%) |
| Dec 2008 | $117.50 M(-43.4%) | $117.50 M(-34.6%) |
| Sept 2008 | - | $179.79 M(-3.6%) |
| June 2008 | - | $186.59 M(-21.9%) |
| Mar 2008 | - | $239.02 M(+15.2%) |
| Dec 2007 | $207.55 M(-3.3%) | $207.55 M(-19.8%) |
| Sept 2007 | - | $258.77 M(-6.5%) |
| June 2007 | - | $276.87 M(+39.9%) |
| Mar 2007 | - | $197.91 M(-7.8%) |
| Dec 2006 | $214.57 M(+30.2%) | $214.57 M(+30.2%) |
| Dec 2005 | $164.78 M | $164.78 M |
FAQ
- What is Jazz Pharmaceuticals annual total assets?
- What is the all time high annual total assets for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly total assets?
- What is the all time high quarterly total assets for Jazz Pharmaceuticals?
- What is Jazz Pharmaceuticals quarterly total assets year-on-year change?
What is Jazz Pharmaceuticals annual total assets?
The current annual total assets of JAZZ is $11.39 B
What is the all time high annual total assets for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high annual total assets is $12.30 B
What is Jazz Pharmaceuticals quarterly total assets?
The current quarterly total assets of JAZZ is $12.26 B
What is the all time high quarterly total assets for Jazz Pharmaceuticals?
Jazz Pharmaceuticals all-time high quarterly total assets is $13.21 B
What is Jazz Pharmaceuticals quarterly total assets year-on-year change?
Over the past year, JAZZ quarterly total assets has changed by +$862.36 M (+7.57%)